Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma

We identified CN gains in the region of 11 useful molecular targets. Findings of variable gains in some regions in this and other studies support the argument for molecular stratification before treatment for CC so that treatment can be tailored to the individual patient.